Ducommun Incorporated Announces Third Quarter Conference Call GlobeNewswire October 23, 2025 COSTA MESA, Calif., Oct. 23, 2025 (GLOBE NEWSWIRE) — Ducommun Incorporated (NYSE: DCO) (“Ducommun” or the “Company”) today announced that it plans to release the Company's 2025 third quarter financial results on November 6, 2025, prior to the stock market opening. Stephen G. Oswald, […]
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors ofZions Bancorporation, N.A. (“Zions Bancorp” or “the Company”) (NASDAQ: ZION) for violations of the securities laws. https://mma.prnewswire.com/media/1396534/Schall_Firm_Logo.jpg The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent
The DJS Law Group reminds investors of a class action lawsuit against Savara Inc. (“Savara ” or “the Company”) (NASDAQ: SVRA ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of SVRA during the
NEW YORK, NY / ACCESS Newswire / October 23, 2025 / If you suffered a loss on your Lantheus Holdings, Inc. (NASDAQ:LNTH) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/lantheus-holdings-inc-lawsuit-submission-form-2?prid=173559&wire=1&utm_campaign=21 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or
NEW YORK, NY / ACCESS Newswire / October 23, 2025 / If you suffered a loss on your Cytokinetics, Incorporated (NASDAQ:CYTK) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/cytokinetics-incorporated-lawsuit-submission-form-2?prid=173561&wire=1&utm_campaign=13 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call
NEW YORK, NY / ACCESS Newswire / October 23, 2025 / If you suffered a loss on your KBR, Inc. (NYSE:KBR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/kbr-inc-lawsuit-submission-form?prid=173560&wire=1&utm_campaign=3 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit againstMolina Healthcare, Inc. (“Molina” or “the Company”) (NYSE: MOH) forviolations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. https://mma.prnewswire.com/media/1396534/Schall_Firm_Logo.jpg Investors who purchased the
The DJS Law Groupannounces that it is investigating claims on behalf of investors of Vera Bradley, Inc. (“Vera Bradley” or “the Company”) (NASDAQ: VRA) for violations of the securities laws. INVESTIGATION DETAILS: The investigation focuses on whether the Company issued misleading statements and/or failed to disclose information pertinent to investors. On Juny 11, 2025, Vera
New York City, NY, Oct. 23, 2025 (GLOBE NEWSWIRE) — Introduction In an era where technology seamlessly integrates into everyday life, ensuring the safety and well-being of pets has become increasingly sophisticated. Furthrive GPS emerges as a revolutionary solution, redefining how pet owners monitor, protect, and train their beloved companions. Combining cutting-edge satellite tracking, intelligent
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors ofZions Bancorporation, N.A. (“Zions Bancorp” or “the Company”) (NASDAQ: ZION) for violations of the securities laws. https://mma.prnewswire.com/media/1396534/Schall_Firm_Logo.jpg The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent